Veteran Owned 1,000+ Five-Star Reviews Become Your Own Inspiration

Hormone Optimization for Both Men and Women — Nationwide

I am trapped between high hematocrit and low iron on TRT. How do people handle that?

Via Telemed — From the Comfort and Privacy of Your Home
The Short Answer

This is a real and common problem. TRT stimulates red blood cell production, raising hematocrit. Frequent blood donation to lower hematocrit can deplete iron (ferritin). The solution is not to keep donating indefinitely — it is to work with your provider on dose adjustment, hydration, injection frequency, and possibly switching delivery methods.

Testosterone stimulates erythropoiesis — the production of red blood cells. In some men, hematocrit rises above the safe range (typically above 52-54%). The standard advice is to donate blood, which works short-term but can tank ferritin (stored iron) with repeated donations.

Low ferritin causes its own problems: fatigue, brain fog, restless legs, and hair loss — symptoms that overlap with low testosterone and make it hard to tell what is helping and what is hurting.

Better long-term strategies include lowering the TRT dose, increasing injection frequency (smaller, more frequent doses cause less erythropoietic stimulation), switching from IM to SubQ, improving hydration, and in some cases switching to a delivery method like nasal or oral testosterone that has less impact on hematocrit.

Iron supplementation while on TRT and donating regularly should be guided by labs — you need to know your ferritin level, not guess. At Viking, hematocrit and ferritin are monitored together so the protocol can be adjusted before you end up stuck between two problems.

Medically reviewed by Dr. Ana Lisa Carr, MD, Medical Director, Viking Alternative Medicine
Published: August 30, 2026 Last medically reviewed: September 16, 2026
This information is for educational purposes. It does not replace a consultation with a licensed provider. Your treatment plan is based on your individual lab results, medical history, and provider assessment.